Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

6.7%

1 terminated/withdrawn out of 15 trials

Success Rate

90.0%

+3.5% vs industry average

Late-Stage Pipeline

7%

1 trials in Phase 3/4

Results Transparency

0%

0 of 9 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
7(46.7%)
Phase 2
6(40.0%)
Phase 4
1(6.7%)
N/A
1(6.7%)
15Total
Phase 1(7)
Phase 2(6)
Phase 4(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (15)

Showing 15 of 15 trials
NCT02566655Phase 1Completed

Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis

Role: collaborator

NCT01329354Phase 2Unknown

Rituximab and Autologous Effector Lymphocytes in Non-Hodgkin Follicular Lymphoma in Response to First Line Chemotherapy

Role: collaborator

NCT01513694Phase 1Completed

Clinical Trial Based on the Use of Mesenchymal Stem Cells From Autologous Bone Marrow in Patients With Lumbar Intervertebral Degenerative Disc Disease

Role: collaborator

NCT02566681Phase 1Unknown

Clinical Trial of Use of Autologous Bone Marrow Stem Cells Seeded on Porous Tricalcium Phosphate Matrix and Demineralized Bone Matrix in Patients With Osteonecrosis

Role: collaborator

NCT02045745Phase 1Unknown

Clinical Trial Phase I/II Prospective, Open Nonrandomized for Treatmen of Postoperative Air Leak After Lung Resection in High Risk Patients Through the Administration of Mesenchymal Autologous Cells

Role: collaborator

NCT02104440Phase 2Completed

Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In Vitro

Role: collaborator

NCT01700920Phase 2Completed

PHASE II CLINICAL TRIAL Prospective, Open, Nonrandomized Treatment of Osteonecrosis of the Femoral Head by the Administration of Autologous Mesenchymal Stem Cells

Role: collaborator

NCT01824368Phase 1Completed

Extracorporeal Photopheresis in Liver Transplantation. Phase II Clinical Trial in Safety and Efficacy in Patients With Gradual Decrease of Immunosuppression.

Role: collaborator

NCT02286011Phase 1Unknown

Intramuscular Infusion of Autologous Bone Marrow Stem Cells in Patients With Amyotrophic Lateral Sclerosis

Role: collaborator

NCT02280135Phase 1Completed

Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa

Role: collaborator

NCT01574092Phase 2Completed

Irinotecan in Combination With Cisplatin in Pediatric Patients With Unfavorable Prognosis Gliomas

Role: collaborator

NCT01529073Phase 2Unknown

Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection

Role: collaborator

NCT01367223Phase 4Completed

Modulation of Systemic Inflammatory Response in Critically Ill Children After Glutamine Supplementation

Role: collaborator

NCT01157013Not ApplicableCompleted

Role of Positron Emission Tomography in the Evaluation of Response to Sorafenib in Advanced Hepatocellular Carcinoma

Role: collaborator

NCT00399425Phase 2Terminated

Efficacy of a Low-Molecular-Weight Heparin (Bemiparin) in the Treatment of Chronic Foot Ulcers in Diabetic Patients

Role: lead

All 15 trials loaded